GALT   $2.28  -0.44% Market Closed After Close 2.28 0.0

Galectin Therapeutics Inc.

EMA (20): 2026-03-18 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2025-12-19 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (100): 2025-12-19 the price crossed down the moving average line and demonstrates a downside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the upper part of the neutral territory and it falls. These factors indicate that the downside trend is confirmed. Last signal: main and signal line crossing.

Trend Type turning down
Power medium strength
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -12.97%
EMA (20) date of signal March 18, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -44.06%
EMA (50) date of signal Dec. 19, 2025, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -44.06%
EMA (100) date of signal Dec. 19, 2025, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal April 17, 2026, 3 a.m.
MACD Signals bearish weakening
MACD Yield 0.0
MACD date of signal April 17, 2026, 3 a.m.
Stochastic Signals bullish weakening
Stochastic Yield 0.0
Stochastic date of signal April 17, 2026, 3 a.m.
Updated April 19, 2026, 11 p.m.